Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

It might be a good idea for short-term investors to avoid this Zacks Rank #5 (Strong Sell) stock for now. However, long-term ...

Pfizer's strength lies in its integrated approach to drug development, from discovery to clinical trials, and finally, ...

Short interest is the number of shares that have been sold short but have not yet been covered or closed out. Short selling is when a trader sells shares of a company they do not own, with the hope ...

Dividend investors are likely to find the stock's 6.7% yield attractive. That yield is the result of a 100% dividend payout ratio -- meaning the company devotes all its profit to the payments -- so ...

Pfizer may look cheap with a ~7% yield, but tight free cash flow, patent cliffs, and limited growth raise downside risk. Read the full analysis before buying.

The pharma company had to scale vaccine production from 200 million annually to 3 billion at the pandemic's peak.